Form 4: Inspire Medical Systems Director, Georgia Melenikiotou, Acquires Restricted Stock Units

Director Georgia Melenikiotou acquired 716 Restricted Stock Units (RSUs) of Inspire Medical Systems, Inc. on May 2, 2024.

Summary

• On May 2, 2024, Georgia Melenikiotou, a director of Inspire Medical Systems, Inc., acquired 716 Restricted Stock Units (RSUs).
• The RSUs were awarded at a price of $0.
• Following the transaction, Melenikiotou directly owns 2,102 shares of common stock.
• The RSUs vest on the earlier of the first anniversary of the grant date or immediately prior to a Change of Control, contingent upon continued employment.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction of stock units to a director. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon continued employment and may also be triggered by a Change of Control event.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of RSUs, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates